Inhibitors of an essential mycobacterialcell walllipase (Rv3802c) as tuberculosis drug leads†
Abstract
The first targeted
* Corresponding authors
a Centenary Institute of Cancer Medicine and Cell Biology, Newtown, NSW, Australia
b
School of Chemistry, The University of Sydney, NSW 2006, Australia
E-mail:
richard.payne@sydney.edu.au
Fax: +61 2 9351 3329
Tel: +61 2 9351 3329
c Sydney Medical School, The University of Sydney, NSW 2006, Australia
The first targeted
N. P. West, K. M. Cergol, M. Xue, E. J. Randall, W. J. Britton and R. J. Payne, Chem. Commun., 2011, 47, 5166 DOI: 10.1039/C0CC05635A
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content